5 Topic Commentaries

Once-Daily Eye Drop for IOP Enters FDA Review

Once-Daily Eye Drop for IOP Enters FDA Review

• 

  Janet Serle, MD

  Glaucoma, Ophthalmology

  •

  Icahn School of Medicine at Mount Sinai

  The once-daily dosing is a great benefit for our patients.

  Source
• 

  Rick Lewis, MD

  Glaucoma, Ophthalmology

  •

  Aerie Pharmaceuticals

  we are seeking approval for once-daily dosing of netarsudil

  Source
• 

  Matthew Cooke, MD

  Ophthalmology

  •

  Mayo Clinic Health System – Eau Claire, Wisconsin

  Usually, glaucoma is first treated with daily eye drops or a laser procedure.

  Source
• 

  Justin Hanes, PhD

  Drug delivery, Ophthalmology

  •

  Johns Hopkins Medicine – Wilmer Eye Institute

  We identified a new way to use a polymer in eye drops that rapidly distributes the drug over the surface of the eye.

  Source
• 

  Laura Ensign, PhD

  Drug delivery, Ophthalmology

  •

  Johns Hopkins Medicine – Wilmer Eye Institute

  Achieving this feat in humans is one of the ‘holy grails’ of drug delivery in the eye.

  Source